Details of the Drug Reposition

General Information of This Drug (ID: DMAK85L)

Drug Name
Natalizumab   DMAK85L
Drug Type
Monoclonal antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Multiple sclerosis DISB2WZI 8A40 Approved [1]
Crohn disease DIS2C5Q8 DD70 Approved [1]
------------------------------------------------------------------------------------

References

1 FDA Approved Drug Products from FDA Official Website.